[1]JournalofMedicinalChemistry,2012,vol.55,p.9346-9361,16
[1]Patent:WO2015/180612,2015,A1
[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-WO2015/180612,2015,A1Locationinpatent:Page/Pagecolumn78;79
1251844-44-6
131747-61-0
886510-09-4
588702-68-5
1060810-86-7
1211540-67-8
1356823-19-2 | 6-Methyl-2-(naphthalen-2-yl)-1,3,6,2-dioxazaborocane-4,8-dione | AA000OKL | MFCD11215218
1259224-00-4 | tert-Butyl 1-(4-aminophenyl)cyclobutylcarbamate | AA000OWL | MFCD18762015
1196-70-9 | 6-Formylindole | AA000P6H | MFCD09744050
119707-74-3 | (S)-3,3'-Dibromo-1,1'-bi-2-naphthol | AA000PEK | MFCD03093629
1198171-18-4 | 1-Bromo-2-(difluoromethyl)-4-fluorobenzene | AA000PMZ | MFCD14698532
1199773-41-5 | N-Butyl 4-(4-bromopyrazol-1-yl)benzenesulfonamide | AA000PVN | MFCD13195728
120099-61-8 | (S)-3-Methoxypyrrolidine | AA000Q7U | MFCD09953438
543739-84-0 | 5-(Trifluoromethyl)-1H-pyrazole-4-carboxylic acid | AA000QKN | MFCD00661951
1260649-11-3 | 2-Bromo-6-piperidinobenzonitrile | AA000QVP | MFCD11037745
1260847-61-7 | 7-Bromo-4,6-dichloroquinazoline | AA000RCP | MFCD13193278